Evaluating Clinical Trial Designs for Investigational Treatments of Ebola Virus Disease

@inproceedings{Cooper2015EvaluatingCT,
  title={Evaluating Clinical Trial Designs for Investigational Treatments of Ebola Virus Disease},
  author={Ben S. Cooper and Maciej F. Boni and Wirichada Pan-ngum and Nicholas P J Day and Peter Horby and Piero Olliaro and Trudie Lang and Nicholas J White and Lisa J. White and John Whitehead},
  booktitle={PLoS medicine},
  year={2015}
}
BACKGROUND Experimental treatments for Ebola virus disease (EVD) might reduce EVD mortality. There is uncertainty about the ability of different clinical trial designs to identify effective treatments, and about the feasibility of implementing individually randomised controlled trials during an Ebola epidemic. METHODS AND FINDINGS A treatment evaluation programme for use in EVD was devised using a multi-stage approach (MSA) with two or three stages, including both non-randomised and… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 62 times over the past 90 days. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 16 references

The design and analysis of sequential clinical trials, revised 2nd edition

  • J Whitehead
  • 1997
Highly Influential
7 Excerpts

Randomised controlled trials for Ebola: practical and ethical issues

  • C Adebamowo, Bah-SowO, F Binka, R Bruzzone, A Caplan
  • PMID:
  • 2014
2 Excerpts

The double triangular test in practice

  • J Whitehead, S Todd
  • Pharm Stat
  • 2004
1 Excerpt

Similar Papers

Loading similar papers…